Conference Reports

American Academy of Dermatology 2019 Annual Meeting (AAD 2019)

Washington DC, US

01 March 2019 - 05 March 2019

3rd Inflammatory Skin Disease Summit (ISDS 2018)

Vienna, Austria

12 December 2018 - 15 December 2018

23rd Asian Australasian Regional Conference of Dermatology 2018

Surabaya

08 August 2018 - 11 August 2018

American Academy of Dermatology (AAD) 2018 Annual Meeting

San Diego, California

16 February 2018 - 20 February 2018

Understanding disease pathology and drug selection to maximise outcomes in schizophrenia treatment

20 Jun 2020

The Lundbeck Neuroscience Symposium was held at Sofitel KL Damansara over 2 days, with extensivediscussions on the management of various mental illnesses. The second day of the symposiumaddressed the topic of schizophrenia management, focusing on treatment goals, the rationale forpartial dopamine D(2) receptor agonism and the use of long-acting injectable (LAI) antipsychotics topromote adherence.

Migraine a risk factor for dementia?

Pearl Toh, 5 days ago

Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.

Daily alcohol intake, certain drugs tied to liver abnormalities in PsA patients

4 days ago

Patients with psoriatic arthritis (PsA) often suffer from liver abnormalities, which are associated with higher body mass index (BMI), daily consumption of alcohol, more severe disease, and some therapies, according to a recent study.

Pembrolizumab + chemo improves PFS in previously untreated, advanced TNBC

Christina Lau, 2 days ago

Pembrolizumab in combination with chemotherapy significantly improves progression-free survival (PFS) vs chemotherapy alone in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), results of the KEYNOTE-355 study have shown.